House Accutane Safety Hearing Will Include Testimony From FDA's Woodcock

FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, is scheduled to testify on patient safety issues related to Roche's acne drug Accutane during a Dec. 5 hearing convened by the House Government Reform Committee.